Abbott Laboratories Net Income 2006-2018 | ABT

Abbott Laboratories annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Abbott Laboratories net income for the quarter ending September 30, 2018 was $0.563B, a 6.63% decline year-over-year.
  • Abbott Laboratories net income for the twelve months ending September 30, 2018 was $886M, a 57.87% decline year-over-year.
  • Abbott Laboratories annual net income for 2017 was $0.477B, a 65.93% decline from 2016.
  • Abbott Laboratories annual net income for 2016 was $1.4B, a 68.35% decline from 2015.
  • Abbott Laboratories annual net income for 2015 was $4.423B, a 93.65% increase from 2014.
Abbott Laboratories Annual Net Income
(Millions of US $)
2017 $477
2016 $1,400
2015 $4,423
2014 $2,284
2013 $2,576
2012 $5,963
2011 $4,728
2010 $4,626
2009 $5,746
2008 $4,881
2007 $3,606
2006 $1,717
2005 $3,372
Abbott Laboratories Quarterly Net Income
(Millions of US $)
Q3 2018 $563
Q2 2018 $733
Q1 2018 $418
Q4 2017 $-828
Q3 2017 $603
Q2 2017 $283
Q1 2017 $419
Q4 2016 $798
Q3 2016 $-329
Q2 2016 $615
Q1 2016 $316
Q4 2015 $767
Q3 2015 $580
Q2 2015 $784
Q1 2015 $2,292
Q4 2014 $905
Q3 2014 $538
Q2 2014 $466
Q1 2014 $375
Q4 2013 $590
Q3 2013 $966
Q2 2013 $476
Q1 2013 $544
Q4 2012 $1,053
Q3 2012 $1,943
Q2 2012 $1,725
Q1 2012 $1,242
Q4 2011 $1,619
Q3 2011 $303
Q2 2011 $1,943
Q1 2011 $864
Q4 2010 $1,441
Q3 2010 $891
Q2 2010 $1,292
Q1 2010 $1,003
Q4 2009 $1,539
Q3 2009 $1,480
Q2 2009 $1,288
Q1 2009 $1,439
Q4 2008 $1,536
Q3 2008 $1,085
Q2 2008 $1,322
Q1 2008 $938
Q4 2007 $1,203
Q3 2007 $717
Q2 2007 $989
Q1 2007 $698
Q4 2006 $-476
Q3 2006 $716
Q2 2006 $612
Q1 2006 $865
Q4 2005 $976
Q3 2005 $681
Q2 2005 $877
Q1 2005 $838
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $123.892B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.046B 18.71
Stryker (SYK) United States $62.759B 23.66
Boston Scientific (BSX) United States $48.834B 24.68
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $23.151B 15.01
Smith & Nephew SNATS (SNN) United Kingdom $15.845B 0.00
ResMed (RMD) United States $14.616B 27.87
Perrigo (PRGO) Ireland $8.530B 12.95
Bio-Rad Laboratories (BIO) United States $8.041B 51.42
Canopy Growth (CGC) Canada $7.608B 0.00
Hill-Rom Holdings (HRC) United States $6.079B 19.27
Aurora Cannabis (ACB) Canada $5.873B 32.05
Haemonetics (HAE) United States $5.316B 46.75
ICU Medical (ICUI) United States $4.835B 26.94
Insulet (PODD) United States $4.492B 0.00
Hutchison China MediTech (HCM) China $4.108B 0.00
Agios Pharmaceuticals (AGIO) United States $3.867B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.782B 0.00
Neogen (NEOG) United States $3.211B 48.63
NuVasive (NUVA) United States $3.153B 29.33
National Vision Holdings (EYE) United States $2.871B 55.54
Quidel (QDEL) United States $2.378B 31.00
Aphria (APHA) $2.260B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.371B 19.41
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $0.999B 1439.50
VAREX IMAGING (VREX) United States $0.974B 19.57
Meridian Bioscience (VIVO) United States $0.833B 26.55
OraSure Technologies (OSUR) United States $0.761B 42.86
Surmodics (SRDX) United States $0.759B 115.98
Eagle Pharmaceuticals (EGRX) United States $0.737B 23.64
MacroGenics (MGNX) United States $0.713B 0.00
PetIQ (PETQ) United States $0.704B 20.01
Cerus (CERS) United States $0.692B 0.00
Lantheus Holdings (LNTH) United States $0.627B 19.41
Omeros (OMER) United States $0.617B 0.00
Owens & Minor (OMI) United States $0.546B 6.18
LeMaitre Vascular (LMAT) United States $0.537B 26.39
NanoString Technologies (NSTG) United States $0.509B 0.00
Insys Therapeutics (INSY) United States $0.499B 0.00
TG Therapeutics (TGTX) United States $0.428B 0.00
Evolus (EOLS) United States $0.377B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.342B 22.12
Cytosorbents (CTSO) United States $0.316B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.258B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.205B 0.00
Bovie Medical (BVX) United States $0.193B 0.00
BioLife Solutions (BLFS) United States $0.186B 250.75
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.116B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.080B 16.68
Female Health (VERU) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.072B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 18.87
CAS Medical Systems (CASM) United States $0.051B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00